Page 15 - Unity Biotechnology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Unity biotechnology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Unity Biotechnology Today - Breaking & Trending Today

Aging rejuvenation is a thing - Fresh interview with Aubrey de Grey

What is aging? We can define aging as a process of accumulation of the damage which is just a side- effect of normal metabolism. While researchers still ....

United States , Sankt Peterburg , United Kingdom , Brian Wang , Ariel Feinerman , Jim Mellon , Josiah Zaynersay , American Aging Association , Gerontological Society Of America , Grey Is Of Rejuvenation Research , Spiegel Lab , Research Foundation , Department Of Defense , Head Of Research , University Of Cambridge , Albert Einstein College Of Medicine , Singularity University , United States Army , Aubrey De Grey , Computer Science , Rejuvenation Research , Gerontological Society , Feinerman Interview , Hello Ariel , Agex Therapeutics , Unity Biotechnology ,

Unity Biotechnology (NASDAQ:UBX) Price Target Cut to $5.00

Unity Biotechnology (NASDAQ:UBX – Get Rating) had its target price reduced by Wedbush from $35.00 to $5.00 in a report issued on Tuesday, The Fly reports. They currently have an outperform rating on the stock. Wedbush also issued estimates for Unity Biotechnology’s FY2026 earnings at ($12.94) EPS and FY2027 earnings at ($15.07) EPS. Several other […] ....

Judith Campisi , Jan Van Deursen , Nathaniel Eames David , Renaissance Technologies , Virtu Financial , Unity Biotechnology Inc , Acadian Asset Management , Unity Biotechnology , Get Rating , Asset Management , Street Corp , Exoduspoint Capital Management , Daohong Zhou , South San Francisco , Unity Biotechnology Daily , Nasdaq Ubx , Lower Price Target ,

Unity Biotechnology, Inc. to Post FY2026 Earnings of ($12.94) Per Share, Wedbush Forecasts (NASDAQ:UBX)

Unity Biotechnology, Inc. (NASDAQ:UBX – Get Rating) – Investment analysts at Wedbush decreased their FY2026 EPS estimates for Unity Biotechnology in a research note issued to investors on Tuesday, March 28th. Wedbush analyst A. Argyrides now anticipates that the company will earn ($12.94) per share for the year, down from their prior estimate of ($12.04). […] ....

Judith Campisi , Jan Van Deursen , Nathaniel Eames David , Schonfeld Strategic Advisors , Capital Investment Advisors , Unity Biotechnology Inc , Dimensional Fund Advisors , Unity Biotechnology , Get Rating , Street Group , Strategic Advisors , Fund Advisors , Prime Capital Investment Advisors , Daohong Zhou , South San Francisco , Unity Biotechnology Daily , Nasdaq Ubx , Earnings Estimates ,

Pets at Home Group Plc (LON:PETS) Receives GBX 365 Average PT from Brokerages

Unity Biotechnology (NASDAQ:UBX – Get Rating) had its price objective reduced by Mizuho from $12.00 to $6.00 in a research report released on Tuesday morning, The Fly reports. They currently have a buy rating on the stock. A number of other equities analysts also recently issued reports on the company. HC Wainwright reissued a buy […] ....

Judith Campisi , Nathaniel Eames David , Jan Van Deursen , Unity Biotechnology Inc , Dimensional Fund Advisors , Capital Investment Advisors , Arete Wealth Advisors , Schonfeld Strategic Advisors , Unity Biotechnology , Get Rating , Wealth Advisors , Street Group , Strategic Advisors , Daohong Zhou , South San Francisco , Unity Biotechnology Daily , Nasdaq Ubx , Lower Price Target ,

Mizuho Trims Unity Biotechnology (NASDAQ:UBX) Target Price to $6.00

Unity Biotechnology (NASDAQ:UBX – Get Rating) had its target price decreased by Mizuho from $12.00 to $6.00 in a report published on Tuesday morning, The Fly reports. Mizuho currently has a buy rating on the stock. UBX has been the topic of a number of other reports. Wedbush reiterated an outperform rating and set a […] ....

Jan Van Deursen , Judith Campisi , Nathaniel Eames David , Unity Biotechnology Company Profile , Capital Management , Unity Biotechnology Inc , Venture Management , Vanguard Group Inc , Unity Biotechnology , Get Rating , Asset Management , Daohong Zhou , South San Francisco , Unity Biotechnology Daily , Nasdaq Ubx , Lower Price Target ,